首页> 外文会议>Annual Meeting of the Japanese Association for Animal Cell Technology >A HUMAN CATALYTIC ANTIBODY WITH THE LIGHT CHAIN RAISED BY SECONDARY VJ RECOMBINATION IN A HUMAN PLASMA CELL LINE
【24h】

A HUMAN CATALYTIC ANTIBODY WITH THE LIGHT CHAIN RAISED BY SECONDARY VJ RECOMBINATION IN A HUMAN PLASMA CELL LINE

机译:一种人催化抗体,用次生血浆细胞系中的次级VJ重组升高的轻链

获取原文

摘要

Immunoglobulin (Ig) gene rearrangements occur in a highly ordered fashion during B-cell development. Continuous rearrangement of the light chain genes has been reported in mature B cells in vivo, but not in Ig-secreting plasma cells. In our previous study, we have identified the antibody-secreting human plasma B-cell line HTD8, which actively replaces the production of the original lambda light chain with a new lambda chain at a high rate. In this study, we examined the peptidolytic activities of theantibodies produced by the plasma cell clones which have occurred secondary recombination to show a possible biological role of the newly-expressed antibodies. An antibody produced by one of the HTD8-derived cells had peptidolytic activities. As a result of sequence analysis, the variable region gene of the antibody light chain belonged to V_(lambda) 6 family. The other antibodies with the light chains belonging to V_(lambda) 6 family did not have such an activity. The difference among V_(lambda) 6-relating antibodies is a sequence diversification occurring in the combining site between variable and joint regions in the light chain. These results suggest that the peptidolytic activity of the antibody is gained by a sequence diversification occurring in the combining site between variable and joining regions in the light chain.
机译:在B细胞发育期间,免疫球蛋白(IG)基因重排以高度有序的方式发生。在体内成熟B细胞中报道了轻链基因的连续重排,但不在IG分泌血浆细胞中。在我们以前的研究中,我们鉴定了抗体分泌的人血浆B细胞系HTD8,其在高速速率下主动取代原来的λ轻链的产生。在这项研究中,我们检查了由血浆细胞克隆产生的肽分解的肽分解活性,所述血浆细胞克隆已经发生了次要重组以显示出新表达抗体的可能生物学作用。由HTD8衍生细胞之一产生的抗体具有肽解活性。作为序列分析的结果,抗体轻链的可变区基因属于V_(Lambda)6家族。与属于V_(Lambda)6家族的轻链的其他抗体没有这样的活性。 V_(Lambda)6关联抗体之间的差异是在轻链中的可变和关节区域之间的组合部位中发生的序列多样化。这些结果表明,通过在轻链中的可变和连接区域之间的组合部位中发生的序列多样化来获得抗体的肽分解活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号